نتایج جستجو برای: ژن های tp53

تعداد نتایج: 489791  

2016
Koichi Takahashi Keyur Patel Carlos Bueso-Ramos Jianhua Zhang Curtis Gumbs Elias Jabbour Tapan Kadia Michael Andreff Marina Konopleva Courtney DiNardo Naval Daver Jorge Cortes Zeev Estrov Andrew Futreal Hagop Kantarjian Guillermo Garcia-Manero

We screened TP53 mutations in 168 MDS patients who were treated with HMA and evaluated predictive and prognostic value of TP53 mutations. Overall response to HMA was not different based on TP53 mutation status (45% vs. 32% in TP53-mutated and wild type [WT], respectively, P = 0.13). However, response duration was significantly shorter in TP53-mutated patients compared to WT patients (5.7 months...

2015
Daniela Kandioler Martina Mittlböck Sonja Kappel Harald Puhalla Friedrich Herbst Cord Langner Brigitte Wolf Jörg Tschmelitsch Walter Schippinger Günther Steger Friedrich Hofbauer Hellmut Samonigg Michael Gnant Bela Teleky Irene Kührer

We investigated the hypothesis that the varying treatment efficacy of adjuvant 5-fluorouracil (5FU) in stage III colon cancer is linked to the TP53 mutational status. ABCSG-90 was a prospective randomized trial in which effect of adjuvant 5FU was studied in stage III colon cancer patients. Tumor material of 70% of these patients (389/572) was available for analysis of the biomarker TP53 using a...

Journal: :Carcinogenesis 2005
Leah E Mechanic Aizen J Marrogi Judith A Welsh Elise D Bowman Mohammed A Khan Lindsey Enewold Yun-Ling Zheng Stephen Chanock Peter G Shields Curtis C Harris

The pattern of somatic mutations in TP53 is distinct for particular cancers and carcinogenic exposures, providing clues to disease etiology, e.g. G:C-->T:A mutations in TP53 are more frequently observed in smoking-associated lung cancers. In order to investigate possible causes and mechanisms of lung cancer susceptibility differences, the TP53 gene was sequenced in a case-only study of lung can...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2009
Davide Rossi Michaela Cerri Clara Deambrogi Elisa Sozzi Stefania Cresta Silvia Rasi Lorenzo De Paoli Valeria Spina Valter Gattei Daniela Capello Francesco Forconi Francesco Lauria Gianluca Gaidano

PURPOSE Del17p13 predicts poor outcome and chemorefractoriness in chronic lymphocytic leukemia (CLL). Conversely, it is unknown whether TP53 mutations carry any prognostic value independent of del17p13. We tested the independent prognostic value of TP53 mutations in CLL. EXPERIMENTAL DESIGN The study was based on a consecutive series of 308 CLL. DNA sequencing of TP53 exons 2 to 10 and del17p...

2015
Ana-Iris Schiefer Christoph Kornauth Ingrid Simonitsch-Klupp Cathrin Skrabs Eva Katharina Masel Berthold Streubel Katrina Vanura Karin Walter Brigitta Migschitz Dagmar Stoiber Veronika Sexl Markus Raderer Andreas Chott Maria Gomes da Silva Jose Cabecadas Leonhard Müllauer Ulrich Jäger Edit Porpaczy

MYC and BCL2 translocations as well as TP53 deletion/mutation are known risk factors in diffuse large B-cell lymphoma (DLBCL) but their interplay is not well understood.In this retrospective cohort study, we evaluated the combined prognostic impact of TP53 deletion and mutation status, MYC and BCL2 genomic breaks in tumor samples of 101 DLBCL patients. The cohort included 53 cases with MYC rear...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007
Leah E Mechanic Elise D Bowman Judith A Welsh Mohammed A Khan Nobutoshi Hagiwara Lindsey Enewold Peter G Shields Laurie Burdette Stephen Chanock Curtis C Harris

Lung cancer is primarily caused by tobacco smoking, but susceptibility is likely modified by common genetic variation. In response to many forms of cellular stress, including DNA damage, the p53 protein functions to induce cell cycle arrest, DNA repair, senescence, or apoptosis. We hypothesized that common TP53 haplotypes modulate pathways of lung carcinogenesis and lung cancer susceptibility o...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2007
Rossella Libè Lionel Groussin Frédérique Tissier Caroline Elie Fernande René-Corail Amato Fratticci Eric Jullian Paolo Beck-Peccoz Xavier Bertagna Christine Gicquel Jérôme Bertherat

PURPOSE Allelic losses [loss of heterozygosity (LOH)] at the 17p13 locus are frequent (85%) in adrenocortical cancers. The tumor suppressor gene TP53 is located at 17p13. The aim of the study was to determine the frequency of TP53 somatic inactivating mutations in adrenocortical tumors with 17p13 LOH and their clinico-biological correlations. EXPERIMENTAL DESIGN TP53 somatic mutations, intrag...

Journal: :Blood 2013
Annika Dufour Giuseppe Palermo Evelyn Zellmeier Gudrun Mellert Guillemette Duchateau-Nguyen Stephanie Schneider Tobias Benthaus Purvi M Kakadia Karsten Spiekermann Wolfgang Hiddemann Jan Braess Sim Truong Nancy Patten Lin Wu Sabine Lohmann David Dornan Debraj GuhaThakurta Ru-Fang Yeh Galina Salogub Philippe Solal-Celigny Anna Dmoszynska Tadeusz Robak Marco Montillo John Catalano Christian H Geisler Martin Weisser Stefan K Bohlander

In chronic lymphocytic leukemia (CLL) patients, disruptions of the TP53 tumor suppressor pathway by 17p13 deletion (del17p), somatic TP53 mutations, or downregulation of microRNA-34a have been associated with a poor prognosis. So far, the impact of the various TP53 defects has not been evaluated in a large cohort of previously treated and relapsed CLL patients. Here, we present the results of T...

Journal: : 2022

هدف: کارآفرینی یکی از عوامل کلیدی در توسعه اقتصادی و شاخص اساسی جوامع روبه‌رشد است. آنچه که کارآفرین را به آغاز فعالیت ترغیب می‌کند، انگیزه فرایند تبدیل یک فرد عادی است می‌تواند فرصت‌هایی ایجاد کند حداکثر رساندن ثروت کمک کند. هدف این پژوهش شناسایی طبقه‌بندی انگیزه‌های کارآفرینان می­باشد.طراحی/ روش‌شناسی/ رویکرد: با رویکرد مرور نظام­مند استفاده ماتریس شش سلولی دو مؤلفه جهت (کشش یا فشار) منبع (اق...

2018
Shigeo Yamaguchi Shin Takahashi Kaoru Mogushi Yuki Izumi Yumi Nozaki Tadashi Nomizu Yoichiro Kakugawa Takanori Ishida Noriaki Ohuchi Chikashi Ishioka Shunsuke Kato

Purpose TP53 signature has a robust predictive performance for prognosis in early-stage breast cancer, but the experiment that reported this relied on public microarray data and fresh-frozen samples. Before TP53 signature can be used in a clinical setting, a simple and low-cost diagnostic system using formalin-fixed paraffin-embedded (FFPE) samples is needed. New treatments based on the biologi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید